The new hepatitis C therapies
Article Sidebar
Main Article Content
Abstract
Hepatitis C Virus (HCV) infection is one of the main causes of chronic liver disease worldwide, with an estimated prevalence of 1% of the world population, corresponding to about 71.1 million people.
In the West, HCV infection is the main cause of end-stage liver disease, hepatocellular carcinoma (HCC) and deaths from liver disease.
HCV infection in Italy still has a prevalence of about 1.1% and remains the main cause of chronic hepatitis, cirrhosis of the liver, HCC and liver transplantation in our country.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
The Polaris Observatory HCV Collaborators; Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterol Hepatol 2017; 2: 161–76.
Rachel H. Westbrook, Geoffrey Dusheiko. Natural history of hepatitis C. Journal of Hepatology 2014 vol. 61 j S58–S68.
https://www.epatitec.info/patologia/epatite-c-hcv. [Online]
https://www.nadironlus.org/wpcontent/uploads/BrochureHIV_HCV_SESSO_WEB.pdf. [Online]
Petruzziello A, Marigliano S, Loquercio G, et al. Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes. World J Gastroenterol. 2016 Sep 14;22(34):7824-40.
Erin Gower, Chris Estes, Sarah Blach, et al. Global epidemiology and genotype distribution of the hepatitis C virus infection. Journal of Hepatology 2014 vol. 61 j S45–S57.
Antonio Riccardo Buonomo, Riccardo Scotto, Biagio Pinchera, et.al. Epidemiology and risk factors for hepatitis C virus genotypes in a high prevalence region in Italy.
Mason AL, Lau JY, Hoang N et.al. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology. 1999 Feb;29(2):328-33.
Fabiani S, Fallahi P, Ferrari SM, et.al. Hepatitis C virus infection and development of type 2 diabetes mellitus: Systematic review and meta-analysis of the literature. Rev Endocr Metab Disord. 2018 Dec;19(4):405-420.
_ European Association for the Study of the Liver. Recommendations on Treatment of Hepatitis C 2018. J Hepatol. 2018
Aug;69(2):461-511.
https://www.aifa.gov.it/sites/default/files/comunicatistampa/Comunicato_AIFA_442.pdf. [Online]
http://www.quotidianosanita.it/allegati/allegato6653546.pdf. [Online]